304 related articles for article (PubMed ID: 30126643)
21. Impact of changed co-amoxiclav susceptibility testing formats on apparent resistance rates for bloodstream Escherichia coli in a long-term surveillance.
Reynolds R; Mushtaq S; Allen MK; Horner C; Longshaw C; Livermore DM
J Antimicrob Chemother; 2022 Mar; 77(4):1206-1208. PubMed ID: 35045166
[No Abstract] [Full Text] [Related]
22. Bacteremia caused by extended-spectrum-β-lactamase-producing Escherichia coli sequence type ST131 and non-ST131 clones: comparison of demographic data, clinical features, and mortality.
Chung HC; Lai CH; Lin JN; Huang CK; Liang SH; Chen WF; Shih YC; Lin HH; Wang JL
Antimicrob Agents Chemother; 2012 Feb; 56(2):618-22. PubMed ID: 22123694
[TBL] [Abstract][Full Text] [Related]
23. Ceftibuten plus amoxicillin-clavulanic acid for oral treatment of urinary tract infections with ESBL producing E. coli and K. pneumoniae: a retrospective observational case-series.
Cohen Stuart J; Leverstein-Van Hall M; Kortmann W; Verlind J; Mulder F; Scharringa J; Fluit A; Ekkelenkamp M
Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):2021-2025. PubMed ID: 30117050
[TBL] [Abstract][Full Text] [Related]
24. Outcomes in UK patients with hospital-acquired bacteraemia and the risk of catheter-associated urinary tract infections.
Melzer M; Welch C
Postgrad Med J; 2013 Jun; 89(1052):329-34. PubMed ID: 23520064
[TBL] [Abstract][Full Text] [Related]
25. Antimicrobial susceptibility and emerging resistance determinants (blaCTX-M, rmtB, fosA3) in clinical isolates from urinary tract infections in the Bolivian Chaco.
Bartoloni A; Sennati S; Di Maggio T; Mantella A; Riccobono E; Strohmeyer M; Revollo C; Villagran AL; Pallecchi L; Rossolini GM
Int J Infect Dis; 2016 Feb; 43():1-6. PubMed ID: 26686940
[TBL] [Abstract][Full Text] [Related]
26. Neonatal Escherichia coli Bloodstream Infections: Clinical Outcomes and Impact of Initial Antibiotic Therapy.
Bergin SP; Thaden JT; Ericson JE; Cross H; Messina J; Clark RH; Fowler VG; Benjamin DK; Hornik CP; Smith PB;
Pediatr Infect Dis J; 2015 Sep; 34(9):933-6. PubMed ID: 26065862
[TBL] [Abstract][Full Text] [Related]
27. A Cohort Study of Risk Factors That Influence Empirical Treatment of Patients with Acute Pyelonephritis.
Bosch-Nicolau P; Falcó V; Viñado B; Andreu A; Len O; Almirante B; Pigrau C
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971876
[TBL] [Abstract][Full Text] [Related]
28. Antibiotic management of urinary tract infection in elderly patients in primary care and its association with bloodstream infections and all cause mortality: population based cohort study.
Gharbi M; Drysdale JH; Lishman H; Goudie R; Molokhia M; Johnson AP; Holmes AH; Aylin P
BMJ; 2019 Feb; 364():l525. PubMed ID: 30814048
[TBL] [Abstract][Full Text] [Related]
29. Prior antibiotics and risk of antibiotic-resistant community-acquired urinary tract infection: a case-control study.
Hillier S; Roberts Z; Dunstan F; Butler C; Howard A; Palmer S
J Antimicrob Chemother; 2007 Jul; 60(1):92-9. PubMed ID: 17540675
[TBL] [Abstract][Full Text] [Related]
30. Incidence and antimicrobial resistance trends in bloodstream infections caused by ESKAPE and Escherichia coli at a large teaching hospital in Rome, a 9-year analysis (2007-2015).
De Angelis G; Fiori B; Menchinelli G; D'Inzeo T; Liotti FM; Morandotti GA; Sanguinetti M; Posteraro B; Spanu T
Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1627-1636. PubMed ID: 29948360
[TBL] [Abstract][Full Text] [Related]
31. A study of the 20-year evolution of antimicrobial resistance patterns of pediatric urinary tract infections in a single center.
Dejonckheere Y; Desmet S; Knops N
Eur J Pediatr; 2022 Sep; 181(9):3271-3281. PubMed ID: 35739294
[TBL] [Abstract][Full Text] [Related]
32. Antibiotic resistance patterns of Escherichia coli urinary isolates and comparison with antibiotic consumption data over 10 years, 2005-2014.
Stapleton PJ; Lundon DJ; McWade R; Scanlon N; Hannan MM; O'Kelly F; Lynch M
Ir J Med Sci; 2017 Aug; 186(3):733-741. PubMed ID: 28054236
[TBL] [Abstract][Full Text] [Related]
33. Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge.
Rodríguez-Baño J; Navarro MD; Romero L; Muniain MA; de Cueto M; Ríos MJ; Hernández JR; Pascual A
Clin Infect Dis; 2006 Dec; 43(11):1407-14. PubMed ID: 17083012
[TBL] [Abstract][Full Text] [Related]
34. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.
Perez KK; Olsen RJ; Musick WL; Cernoch PL; Davis JR; Peterson LE; Musser JM
J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135
[TBL] [Abstract][Full Text] [Related]
35. Five-Year Antimicrobial Resistance Patterns of Urinary Escherichia coli at an Australian Tertiary Hospital: Time Series Analyses of Prevalence Data.
Fasugba O; Mitchell BG; Mnatzaganian G; Das A; Collignon P; Gardner A
PLoS One; 2016; 11(10):e0164306. PubMed ID: 27711250
[TBL] [Abstract][Full Text] [Related]
36. Trends in Antimicrobial Susceptibility of
Chen HE; Tain YL; Kuo HC; Hsu CN
Antibiotics (Basel); 2020 Aug; 9(8):. PubMed ID: 32785113
[TBL] [Abstract][Full Text] [Related]
37. Intra-hospital differences in antibiotic use correlate with antimicrobial resistance rate in
Cusini A; Herren D; Bütikofer L; Plüss-Suard C; Kronenberg A; Marschall J
Antimicrob Resist Infect Control; 2018; 7():89. PubMed ID: 30069305
[TBL] [Abstract][Full Text] [Related]
38. Patterns in the epidemic of Escherichia coli bloodstream infection in Oxfordshire.
Jenkins DR
Lancet Infect Dis; 2018 Oct; 18(10):1057-1058. PubMed ID: 30126644
[No Abstract] [Full Text] [Related]
39. Selection and co-selection of antibiotic resistances among Escherichia coli by antibiotic use in primary care: An ecological analysis.
Pouwels KB; Muller-Pebody B; Smieszek T; Hopkins S; Robotham JV
PLoS One; 2019; 14(6):e0218134. PubMed ID: 31181106
[TBL] [Abstract][Full Text] [Related]
40. Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998-2007.
Al-Hasan MN; Lahr BD; Eckel-Passow JE; Baddour LM
J Antimicrob Chemother; 2009 Jul; 64(1):169-74. PubMed ID: 19435736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
